Forbes November 20, 2023
The Food and Drug Administration recently approved a vaccine against chikungunya (pronounced chi-kuhn-goo-nyuh), a virus spread by mosquitoes in tropical areas across the globe. Most infections are mild and patients recover, but there are reasons having a vaccine makes sense: chikungunya spreads like wildfire, there is no treatment and it can cause devastating long-term disability. Prevention is our best defense.
The Disease
Chikungunya virus causes a disease similar to dengue fever, with high fever, headache, pain behind the eyes, sore throat, fatigue, body aches, joint pains and a red, spotty rash. Symptoms resolve for most people after a week to 10 days, but debilitating joint pain can persist for months or longer in others. The name chikungunya, from the Maconde...
Today's Sponsors
Today's Sponsor